DLDiogo L. L. Leao

Diogo L. L. Leao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diogo L. L. Leao has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Milena Pavlova

    Affiliation Department of Health Services Research, CAPHRI, Maastricht University Medical Center, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands

    7 shared publications
  • Dennis van Veghel

    Netherlands Heart Network Eindhoven The Netherlands

    5 shared publications
  • Wim Groot

    Department of Health Services Research CAHPRI, Maastricht University Medical Center Faculty of Health, Medicine and Life Sciences Maastricht University Maastricht the Netherlands

    5 shared publications
  • Henricus-Paul Cremers

    MAASTRO, Maastricht, The Netherlands

    4 shared publications
  • Lise A. M. Moers

    Netherlands Heart Network Eindhoven The Netherlands

    3 shared publications
  • Wim N. J. Groot

    Department of Health Services Research CAHPRI Maastricht University Medical Center Maastricht The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    Barriers and Strategies for Inclusion of Value‐Based Healthcare in Contract Negotiations in the Netherlands: Study Among Hospital and Insurer Executives

    by Diogo L. L. Leao, Dennis van Veghel, Lise A. M. Moers, Wim Groot, Milena Pavlova

    Background: This paper analyses why, despite its recognized importance, value‐based healthcare (VBHC) has not gained more prominence in negotiations between health insurers and hospitals in the Netherlands. Methods: Data collected by interviews used a standardized questionnaire with closed‐ and open‐ended questions. Respondents included hospital and insurer executives, and experts on VBHC in the Netherlands. Results: Hospital and insurer executives addressed issues of cost containment, volume management, and care availability. Despite recognising the potential of VBHC to enhance patient outcomes and experiences, reluctance persists due to uncertainties about cost‐savings, its complexity, lack of data, and competing priorities. Hospital executives advocated experiments with VBHC, trust‐building, and continuous evaluation, with strategies to standardise measures, enhance information technology (IT) infrastructure, promote data transparency, foster collaboration, and educate stakeholders. Participants also underlined the need for systemic change and governmental action. Conclusions: Negotiations mostly focus on cost containment and volume management. This reflects a systemic emphasis on immediate financial concerns over long‐term value creation. The hesitancy in transitioning to VBHC underscores the need for collaborative strategies and systemic shifts to prioritise patient‐centric care. External factors such as fee‐for‐service payment systems further complicate VBHC adoption, requiring governmental intervention and cultural transformation to align incentives and promote sustainable healthcare practices.


  • Open Access

    Design, implementation and evaluation of value-based payment models: a Delphi study

    by Diogo L. L. Leao, Lise A. M. Moers, Henricus-Paul Cremers, Dennis van Veghel, Wim Groot, Milena Pavlova

    This study explores the facilitating and inhibiting factors in the design/development, implementation, and applicability/evaluation of value-based payment models of integrated care. The Delphi technique was used to reach consensus among a panel of (inter)national experts on these factors. An expert panel of 15 members participated in a three-round Delphi study. Factors from experts and literature were used to compile a list of 40 facilitators and 40 inhibitors. Afterwards, experts were asked to rate the importance of these factors using a 5-point Likert scale. Eight facilitating (e.g., transparency, communication, and trust among involved stakeholders) and seven inhibiting factors (e.g., lack of motivation and engagement among involved stakeholders) achieved full consensus. Timely availability of data and an integrated information technology system for data registration (a facilitator) were the only factors achieving full consensus through a very high agreement. Adequate outcome measures, targets, benchmarks, and incentives are important in value-based payment models. The less quantifiable items, such as strong leadership, transparency, communication and trust, and motivation and engagement of the involved stakeholders, are also important for successful adoption of these models and promote high-quality care at lower or equal costs. – Delphi study identifies key facilitating and inhibiting factors for effective value-based payment models. – Success of these models relies on measurable factors such as outcome measures, and intangibles like trust and leadership. – "Hard-to-measure" contextual factors play an important role in value-based payment model success across healthcare organizations. – Prioritize teamwork and clear goals before tailoring these models for optimal value, benefiting patients globally.


  • Facilitating and inhibiting factors affecting the Netherlands Heart Network

    by Diogo L. L. Leao, Lise A. M. Moers, Henricus-Paul Cremers, Dennis van Veghel, Wim Groot, Milena Pavlova

  • Open Access

    How to facilitate the introduction of value‐based payment models?

    by Diogo L. L. Leao, Milena Pavlova, Wim N. J. Groot

    Value‐based payment (VBP) models are designed and implemented to improve outcomes at the same or lower costs. Their adoption requires significant changes in the way healthcare organisations and insurance companies operate. Usually, before VBP models are widely implemented, pilot projects are conducted. Payers need to have a comprehensive set of requirements to enter into agreements with healthcare organisations on these pilots. In this short communication, we outline key elements reported in the literature, inside and outside healthcare organisations, as well as within the contract, that need to be considered in a pilot VBP model. Discussions regarding the introduction of VBP models may be strongly affected by external contextual factors, including regulations, which are outside the control of healthcare organisations. It requires collaboration between organisations, including primary care organisations and hospitals, while within organisations, it frequently requires creating multidisciplinary teams. The focus is on ensuring transparency, collaboration, and shared decision‐making, realised by standardising communication processes and regular meetings. Additionally, effective leadership is needed, in which leaders set goals and priorities, as well as manage change. In the contractual agreements between payers and healthcare organisations, outcome measures need to be adequately defined and measured, including individual patient outcomes and composite scores, as well as absolute and relative performance measures. These measures should be tested periodically and catered to the organisations adopting the model. Also, incentives should have adequate size and frequency and be intrinsic and extrinsic. The consideration of these sets of key elements by the payers is essential when implementing VBP model pilot projects.


  • Open Access

    Risk selection reduces efficiency of value‐based healthcare

    by Diogo L. L. Leao, Milena Pavlova, Wim Groot

    Value‐based healthcare aims to improve efficiency and value for patients. Value‐based payment models are a form of provider reimbursement to achieve this. Studies on these models have found positive results, but may be biased by unintended consequences, such as risk selection. Risk selection is a multi‐dimensional phenomenon that occurs at the patient, hospital, and system level, and is a source of inefficiency and inequality in healthcare. Risk selection may occur because of selection bias in the outcomes that are evaluated and rewarded, or due to the selection of lower cost patients. Risk selection may also stem from professional reputation. The motivation to engage in risk selection may also arise from differences in the meaning of value. To mitigate these unintended consequences, several strategies can be adopted. These include making value‐based payment models attractive, but not mandatory, as well as incentivising transparent reporting of best practices, using adequate risk adjustment, expanding performance metrics, and including patient‐reported experience measures. Other mitigation strategies could include adopting a mixture of performance measures, using mixed methods of paying physicians, and implementing monitoring and evaluation mechanisms. However, such approaches are not flawless, and the problem may never be fully solved. This perspective serves as a warning for the constant presence of risk selection, as well as informing policy makers, politicians, and organisations implementing VBP models on ways to minimise the possibility of risk selection.


  • Open Access

    Facilitating and Inhibiting Factors in the Design, Implementation, and Applicability of Value-Based Payment Models: A Systematic Literature Review

    by Diogo L. L. Leao, Henricus-Paul Cremers, Dennis van Veghel, Milena Pavlova, Frederique J. Hafkamp, Wim N. J. Groot

    Evidence on the potential for value-based payment models to improve quality of care and ensure more efficient outcomes is limited and mixed. We aim to identify the factors that enhance or inhibit the design, implementation, and application of these models through a systematic literature review. We used the PRISMA guidelines. The facilitating and inhibiting factors were divided into subcategories according to a theoretical framework. We included 143 publications, each reporting multiple factors. Facilitators on objectives and strategies, such as realistic/achievable targets, are reported in 56 studies. Barriers regarding dedicated time and resources (e.g., an excessive amount of time for improvements to manifest) are reported in 25 studies. Consensus within the network regarding objectives and strategies, trust, and good coordination is essential. Health care staff needs to be kept motivated, well-informed, and actively involved. In addition, stakeholders should manage expectations regarding when results are expected to be achieved.


  • Open Access

    The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review

    by Diogo L. L. Leao, Henricus-Paul Cremers, Dennis van Veghel, Milena Pavlova, Wim Groot

    Introduction Value-based healthcare has potential for cost control and quality improvement. To assess this, we review the evidence on the impact of value-based payment (VBP) models in the context of networks of care (NOC) and transmural care. Methods We used the PRISMA guidelines for this systematic literature review. We searched eight databases in July 2021. Subsequently, we conducted title and abstract and full-text screenings, and extracted information in an extraction matrix. Based on this, we assessed the evidence on the effects of VBP models on clinical outcomes, patient-reported outcomes/experiences, organization-related outcomes/experiences, and costs. Additionally, we reviewed the facilitating and inhibiting factors per VBP model. Findings Among articles studying shared savings and pay-for-performance models, most outline positive effects on both clinical and cost outcomes, such as preventable hospitalizations and total expenditures, respectively. Most studies show no change in patient satisfaction and access to care when adopting VBP models. Providers’ opinions towards the models are frequently negative. Transparency and communication among involved stakeholders are found to be key facilitating factors, transversal to all models. Additionally, a lack of trust is an inhibitor found in all VBP models, together with inadequate targets and insufficient incentives. In bundled payment and pay-for-performance models, complexity in the structure of the program and lack of experience in implementing required mechanisms are key inhibitors. Conclusions The overall positive effect on clinical and cost outcomes validates the success of VBP models. The mostly negative effects on organization-reported outcomes/experiences are corroborated by findings regarding providers’ lack of awareness, trust, and engagement with the model. This may be justified by their exclusion from the design of the models, decreasing their sense of ownership and, therefore, motivation. Incentives, targets, benchmarks, and quality measures, if adequately designed, seem to be important facilitators, and if lacking or inadequate, they are key inhibitors. These are prominent facilitators and inhibitors for P4P and shared savings models but not as prominent for bundled payments. The complexity of the scheme and lack of experience are prominent inhibitors in all VBP models, since all require changes in several areas, such as behavioral, process, and infrastructure.